Literature DB >> 27322044

Results of the Women's Self-Performed Anal Pap Trial in Human Immunodeficiency Virus-Infected Women.

Candice J McNeil1, Christina S Kong, Andrew Anglemyer, Vivian Levy, Yvonne Maldonado.   

Abstract

High-risk human papillomavirus anal infections are common in human immunodeficiency virus-infected women. We conducted a cross-over study in 30 women seen in a California human immunodeficiency virus clinic, to test the feasibility of self-performed anal Pap smears. Women found the tests acceptable and feasible. Compared with physician-collected specimens, results were highly concordant for anal cytology (κ = 0.53) and high-risk human papillomavirus typing (κ = 0.59 inclusive of equivocal results, or κ = 0.81 excluding equivocal results).

Entities:  

Mesh:

Year:  2016        PMID: 27322044      PMCID: PMC5529165          DOI: 10.1097/OLQ.0000000000000448

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  14 in total

1.  Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study.

Authors:  Marc T Goodman; Yurii B Shvetsov; Katharine McDuffie; Lynne R Wilkens; Xuemei Zhu; Pamela J Thompson; Lily Ning; Jeffrey Killeen; Lori Kamemoto; Brenda Y Hernandez
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

Review 2.  The 2001 Bethesda System: terminology for reporting results of cervical cytology.

Authors:  Diane Solomon; Diane Davey; Robert Kurman; Ann Moriarty; Dennis O'Connor; Marianne Prey; Stephen Raab; Mark Sherman; David Wilbur; Thomas Wright; Nancy Young
Journal:  JAMA       Date:  2002-04-24       Impact factor: 56.272

Review 3.  HIV infection, aging, and immune function: implications for cancer risk and prevention.

Authors:  Robert Dubrow; Michael J Silverberg; Lesley S Park; Kristina Crothers; Amy C Justice
Journal:  Curr Opin Oncol       Date:  2012-09       Impact factor: 3.645

4.  High Prevalence of Anal Human Papillomavirus-Associated Cancer Precursors in a Contemporary Cohort of Asymptomatic HIV-Infected Women.

Authors:  Isabelle Heard; Isabelle Etienney; Valérie Potard; Isabelle Poizot-Martin; Catherine Moore; Anne-Carole Lesage; Emmanuelle Ressiot; Catherine Crenn-Hebert; Jean-François Fléjou; Heather Cubie; Dominique Costagliola; Teresa M Darragh
Journal:  Clin Infect Dis       Date:  2015-02-02       Impact factor: 9.079

5.  Efficiency of the hybrid capture 2 HPV DNA test in cervical cancer screening. A study by the French Society of Clinical Cytology.

Authors:  Patricia de Cremoux; Joël Coste; Xavier Sastre-Garau; Martine Thioux; Christelle Bouillac; Sylvain Labbé; Isabelle Cartier; Marianne Ziol; Anne Dosda; Catherine Le Galès; Vincent Molinié; Marie-Cécile Vacher-Lavenu; Béatrix Cochand-Priollet; Philippe Vielh; Henri Magdelénat
Journal:  Am J Clin Pathol       Date:  2003-10       Impact factor: 2.493

6.  Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men.

Authors:  Peter V Chin-Hong; J Michael Berry; Su-Chun Cheng; Joseph A Catania; Maria Da Costa; Teresa M Darragh; Fred Fishman; Naomi Jay; Lance M Pollack; Joel M Palefsky
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

7.  High performance and acceptability of self-collected rectal swabs for diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae in men who have sex with men and women.

Authors:  Jannie J van der Helm; Christian J P A Hoebe; Martijn S van Rooijen; Elfi E H G Brouwers; Han S A Fennema; Harold F J Thiesbrummel; Nicole H T M Dukers-Muijrers
Journal:  Sex Transm Dis       Date:  2009-08       Impact factor: 2.830

8.  Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:  Judith A Aberg; Joel E Gallant; Khalil G Ghanem; Patricia Emmanuel; Barry S Zingman; Michael A Horberg
Journal:  Clin Infect Dis       Date:  2014-01       Impact factor: 9.079

9.  A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities.

Authors:  Bruce Shiramizu; Cris Milne; Kevin Terada; Kevin Cassel; Rayna K Matsuno; Jeffery Killeen; Chin-Yuan Liang; Faye Tachibana; Tom Sheeran; James Weihe; Marc T Goodman
Journal:  J AIDS Clin Res       Date:  2012-07-13

10.  Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.

Authors:  Ahmedin Jemal; Edgar P Simard; Christina Dorell; Anne-Michelle Noone; Lauri E Markowitz; Betsy Kohler; Christie Eheman; Mona Saraiya; Priti Bandi; Debbie Saslow; Kathleen A Cronin; Meg Watson; Mark Schiffman; S Jane Henley; Maria J Schymura; Robert N Anderson; David Yankey; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2013-01-07       Impact factor: 13.506

View more
  3 in total

1.  Gaps in Human Papillomavirus Knowledge May Serve as Barriers to Broad Anal Cytology Testing Uptake in At-Risk Women.

Authors:  Candice J McNeil; Vivian Levy
Journal:  J Low Genit Tract Dis       Date:  2021-10-01       Impact factor: 3.842

2.  Rationale and design of the Prevent Anal Cancer Self-Swab Study: a protocol for a randomised clinical trial of home-based self-collection of cells for anal cancer screening.

Authors:  Alan G Nyitray; Vanessa Schick; Michael D Swartz; Anna R Giuliano; Maria E Fernandez; Ashish A Deshmukh; Timothy J Ridolfi; Christopher Ajala; Bridgett Brzezinski; Micaela Sandoval; Belinda Nedjai; Jennifer S Smith; Elizabeth Y Chiao
Journal:  BMJ Open       Date:  2021-06-29       Impact factor: 2.692

3.  Anal Cancer and Anal Cancer Screening Knowledge, Attitudes, and Perceived Risk Among Women Living With HIV.

Authors:  Serena A Rodriguez; Robin T Higashi; Andrea C Betts; Cynthia Ortiz; Jasmin A Tiro; Amneris E Luque; Arti Barnes
Journal:  J Low Genit Tract Dis       Date:  2021-01-01       Impact factor: 3.842

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.